“Saddle” Tailored Upper Eyelid Island Myocutaneous Flap to Repair Full-Thickness Lower Eyelid Defects After Melanoma Excision

2011 ◽  
Vol 27 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Lorenzo Borgognoni ◽  
Serena Sestini ◽  
Gianni Gerlini ◽  
Paola Brandani ◽  
Vanni Giannotti ◽  
...  
2021 ◽  
Vol 10 (2) ◽  
pp. 98-102
Author(s):  
Stefano Mori ◽  
Gianluca Di Monta ◽  
Ugo Marone ◽  
Gerardo Botti ◽  
◽  
...  

1998 ◽  
Vol 21 (5) ◽  
pp. 246-248 ◽  
Author(s):  
E. Porfiris ◽  
P. Georgiou ◽  
C. V. Popa ◽  
A. Christopoulos ◽  
P. Sandris ◽  
...  

2021 ◽  
Vol 14 (8) ◽  
pp. 1168-1173
Author(s):  
Ben Chen ◽  
◽  
Jia Liu ◽  
Xiu-Ying Zhu ◽  
Yan-Yan Lin ◽  
...  

AIM: To investigate the suitability of a modified Hughes procedure, which consists of conjunctival flap with auricular cartilage grafting in reconstructing large full thickness upper and lower eyelid defect. METHODS: Patients with full thickness eyelid carcinoma involving more than 50% margin length who underwent surgical resection were retrospectively reviewed in the study. The defects were reconstructed using conjunctival flap with auricular cartilage grafting, covered with myocutaneous flap above. Followed-up time ranged from 12 to 24mo. Outcomes were classified as “good”, “fair”, and “poor” by evaluating the margin appearance, eyelid appearance, and complications. RESULTS: A total of 42 patients were enrolled in the study (26 males, 16 females, mean age, 68.6±7.7y, range: 53 to 82y). The mean defect widths measured 23.2±2.9 mm (range, 17 to 28 mm). The mean posterior lamellar defect height was 5.5±1.3 mm (4 to 8 mm). Thirty-seven patients had a “good” outcome (88.1%), 5 patients had a “fair” outcome (11.9%), and no one had a “poor” outcome. CONCLUSION: Conjunctival flap with auricular cartilage grafting and myocutaneous flap grafting is an effective procedure in reconstructing large full thickness upper and lower eyelid defect. It can not only achieve satisfied reconstruction, but also preserve intact tarsal plate of the opposite eyelid, avoiding retraction or entropion.


2018 ◽  
Vol 41 (5) ◽  
pp. 412-420 ◽  
Author(s):  
S. Lemaître ◽  
C. Lévy-Gabriel ◽  
L. Desjardins ◽  
M. González-Candial ◽  
S. Gardrat ◽  
...  

2021 ◽  
Vol 24 (4) ◽  
pp. 413-418
Author(s):  
Muhammad Omar Afzal ◽  
Yawar Sajjad ◽  
Kamran Khalid ◽  
Moazzam Nazeer Tarar

Background/Objective: Traumatic loss of the lower eye lid is usually combined with the paucity of adjacent flaps to reconstruct composite defects. We describe the use of Glabellar flaps with composite or cartilage graft to reconstruct total or near total composite lower eyelid defects and its outcome. Material and Methods: This case series was done from January 2017 to December 2019. Patients of either gender, with unilateral post traumatic partial or full thickness lower eyelid defect of 75% eyelid loss or more and Glabellar flap as only remaining option to reconstruct the anterior lamella were included. Patients with medial, lateral canthi, upper eyelid and injuries to orbital contents were excluded. The outcome was assessed on follow-up by the presence of epiphora, ectropion, lagophthalmos, obstruction of vision, graft infection/ extrusion, lower lid retraction, donor site scarring and the need for flap debulking. Results: 12 patients were operated for lower eyelid defects. 2 (16.7%) patients had total loss of eyelid, while 10 (83.3%) had near total loss, 7 (58.3%) patients presented with partial thickness loss of the eyelid, while rest presented with full thickness loss. 1 patient (8.3%) presented with epiphora, similarly 1 (8.3%) had obstruction of vision in down gaze and 1 (8.3%) had conjunctivitis. None had any other complaint. Conclusion: Glabellar flap together with composite or cartilage graft is an excellent option to reconstruct total or near total composite lower eyelid defects.


2011 ◽  
pp. 100-104
Author(s):  
Thi Thu Nguyen ◽  
Viet Hien Vo ◽  
Thi Em Do

The study use intralesional triamcinolone acetonide injection proceduce for chalazion treatment.1. Objectives: To evaluate results of intralesional triamcinolone acetonide injection for chalazion treatment. 2. Method: This noncomparative prospective interventional trial included 72 chalazions of 61 patients. 3. Results: 61 patients (72 chalazions) with 19 males (31.1%) và 42 females (68.9%), the mean age was 24 ± 9,78 years. 31.1% patients was the first time chalazion and 68.9% patients was more than one times chalazion including 78.6% patients was recurrent at the first position and 21.4% patients occur at new position. 72 chalazions with 16 (22.2%) chalazions was treated before and 56 (77.8%) chalazions wasn’t done that. 72 chalazions with 49 chalazions (68.1%) are local in upper eyelid and 23 chalazions (31.9%) are local in lower eyelid. The mean of chalazion diameter is 6.99 ± 3.03mm. Intralesional triamcinolone acetonide is injected to treat 72 chalazions with 16 (22.2%) chalazions are injected through the route of skin and 56 (77.8%) chalazions are injected through the route of conjunctiva. After 2 weeks follow-up, the success rate was 93.1% and 6.9% failed. 4. Conclusion: intralesional triamcinolone acetonide injection for chalazion treatment is really effective. Key words: chalazion, intralesional triamcinolone acetonide.


2002 ◽  
Vol 110 (7) ◽  
pp. 1636-1643 ◽  
Author(s):  
Glenn W. Jelks ◽  
Paul M. Glat ◽  
Elizabeth B. Jelks ◽  
Michael T. Longaker

Sign in / Sign up

Export Citation Format

Share Document